JP2009537542A5 - - Google Patents

Download PDF

Info

Publication number
JP2009537542A5
JP2009537542A5 JP2009511057A JP2009511057A JP2009537542A5 JP 2009537542 A5 JP2009537542 A5 JP 2009537542A5 JP 2009511057 A JP2009511057 A JP 2009511057A JP 2009511057 A JP2009511057 A JP 2009511057A JP 2009537542 A5 JP2009537542 A5 JP 2009537542A5
Authority
JP
Japan
Prior art keywords
pyrrolidin
dimethylamino
carbonyl
phenyl
benzoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009511057A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009537542A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/011765 external-priority patent/WO2007136668A2/en
Publication of JP2009537542A publication Critical patent/JP2009537542A/ja
Publication of JP2009537542A5 publication Critical patent/JP2009537542A5/ja
Withdrawn legal-status Critical Current

Links

JP2009511057A 2006-05-19 2007-05-16 ヒスタミン−3アンタゴニストとしてのn−ベンゾイルピロリジン−3−イルアミンおよびn−ベンジルピロリジン−3−イルアミン Withdrawn JP2009537542A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80190506P 2006-05-19 2006-05-19
PCT/US2007/011765 WO2007136668A2 (en) 2006-05-19 2007-05-16 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists

Publications (2)

Publication Number Publication Date
JP2009537542A JP2009537542A (ja) 2009-10-29
JP2009537542A5 true JP2009537542A5 (cg-RX-API-DMAC7.html) 2010-07-08

Family

ID=38616614

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009511057A Withdrawn JP2009537542A (ja) 2006-05-19 2007-05-16 ヒスタミン−3アンタゴニストとしてのn−ベンゾイルピロリジン−3−イルアミンおよびn−ベンジルピロリジン−3−イルアミン

Country Status (12)

Country Link
US (1) US7842715B2 (cg-RX-API-DMAC7.html)
EP (1) EP2027086B1 (cg-RX-API-DMAC7.html)
JP (1) JP2009537542A (cg-RX-API-DMAC7.html)
CN (1) CN101432261A (cg-RX-API-DMAC7.html)
AR (1) AR061015A1 (cg-RX-API-DMAC7.html)
AT (1) ATE533744T1 (cg-RX-API-DMAC7.html)
AU (1) AU2007254232A1 (cg-RX-API-DMAC7.html)
CA (1) CA2649913A1 (cg-RX-API-DMAC7.html)
MX (1) MX2008014743A (cg-RX-API-DMAC7.html)
PE (1) PE20080371A1 (cg-RX-API-DMAC7.html)
TW (1) TW200811165A (cg-RX-API-DMAC7.html)
WO (1) WO2007136668A2 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008011791A (es) * 2006-03-15 2008-09-25 Wyeth Corp Azaciclilaminas-n-sustituidas como antagonistas de histamina-3.
TW200823204A (en) * 2006-10-17 2008-06-01 Arena Pharm Inc Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine H3-receptor useful for the treatment of disorders related thereto
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP2242745A1 (de) * 2008-02-07 2010-10-27 Sanofi-Aventis Neue phenyl-substituierte imidazolidine, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2009143153A1 (en) * 2008-05-23 2009-11-26 Janssen Pharmaceutica Nv Substituted pyrrolidine amides as modulators of the histamine h3 receptor
US20100063047A1 (en) * 2008-09-10 2010-03-11 Kalypsys, Inc. Aminopyrimidine inhibitors of histamine receptors for the treatment of disease
JP2013545737A (ja) * 2010-11-01 2013-12-26 ニューロチューン・アクチエンゲゼルシャフト 新規ニューロトリプシン阻害剤
US8828994B2 (en) 2011-03-08 2014-09-09 Sanofi Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2766349B1 (de) 2011-03-08 2016-06-01 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683699B1 (de) 2011-03-08 2015-06-24 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8828995B2 (en) 2011-03-08 2014-09-09 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683700B1 (de) 2011-03-08 2015-02-18 Sanofi Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
CN102784146A (zh) * 2011-05-19 2012-11-21 复旦大学 N-苯基喹唑啉-4-胺类衍生物的药用用途

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1416872A (en) * 1972-03-10 1975-12-10 Wyeth John & Brother Ltd 4-aminoquinoline derivatives
US3933829A (en) * 1974-08-22 1976-01-20 John Wyeth & Brother Limited 4-Aminoquinoline derivatives
US4159331A (en) * 1978-05-05 1979-06-26 The Upjohn Company Antihypertensive 4-aminoquinolines
US4166853A (en) * 1978-05-05 1979-09-04 The Upjohn Company Antihypertensive 7-trifluoromethyl-4-aminoquinolones
DK111387A (da) 1986-03-05 1987-09-06 Otsuka Pharma Co Ltd Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
KR100238346B1 (ko) 1993-04-07 2000-03-02 오쓰까 아끼히꼬 피페리딘 유도체를 유효성분으로 하는 말초혈관확장제
IL117149A0 (en) * 1995-02-23 1996-06-18 Schering Corp Muscarinic antagonists
US5747485A (en) * 1995-04-13 1998-05-05 Merck & Co., Inc. Substituted azetidiones as anti-inflammatory and antidegenerative agents
TW531537B (en) 1995-12-27 2003-05-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives
EP1019047B1 (en) 1997-05-01 2003-11-05 Eli Lilly And Company Antithrombotic agents
JP2001526178A (ja) 1997-08-28 2001-12-18 メルク エンド カムパニー インコーポレーテッド ピロリジン系およびピペリジン系ケモカイン受容体活性調節剤
TR200001399T2 (tr) * 1997-11-18 2000-11-21 Teijin Limited Siklik amin türevleri ve ilaç olarak kullanımları.
EP1098892A1 (en) 1998-07-20 2001-05-16 MERCK PATENT GmbH Biphenyl derivatives
KR20010101203A (ko) 1998-12-15 2001-11-14 로즈 암스트롱, 크리스틴 에이. 트러트웨인 Mek 저해제의 이식 조직 거부를 예방하기 위한 용도
AU1734401A (en) * 1999-12-09 2001-06-18 Mitsubishi Pharma Corporation Carboxyamido derivatives
WO2001074773A2 (en) 2000-03-31 2001-10-11 Ortho Mcneil Pharmaceutical, Inc. Phenyl-substituted indoles as histamine h3-receptor antagonists
EP1351936A1 (en) 2001-01-15 2003-10-15 Glaxo Group Limited Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
HN2002000156A (es) * 2001-07-06 2003-11-27 Inc Agouron Pharmaceuticals Derivados de benzamida tiazol y composiciones farmaceuticas para inhibir la proliferacion de celulas y metodos para su utilización.
GB0120461D0 (en) 2001-08-22 2001-10-17 Astrazeneca Ab Novel compounds
WO2003040402A2 (en) 2001-11-09 2003-05-15 The Regents Of The University Of California Alpha-helix mimicry by a class of organic molecules
DK1499311T3 (da) * 2002-03-29 2010-03-08 Novartis Vaccines & Diagnostic Substituerede benzaboler og anvendelse deraf som RAF-kinaseinhibitorer
AU2003226250B2 (en) 2002-04-08 2007-08-16 Merck Sharp & Dohme Corp. Inhibitors of Akt activity
US20040102360A1 (en) * 2002-10-30 2004-05-27 Barnett Stanley F. Combination therapy
WO2004052858A2 (en) 2002-12-06 2004-06-24 Eli Lilly And Company Inhibitors of monoamine uptake
MXPA05009667A (es) 2003-03-14 2006-01-27 Avidex Ltd Compuestos heterociclicos inmunomoduladores.
TW200505902A (en) * 2003-03-20 2005-02-16 Schering Corp Cannabinoid receptor ligands
WO2005000309A2 (en) 2003-06-27 2005-01-06 Ionix Pharmaceuticals Limited Chemical compounds
BRPI0511139B8 (pt) * 2004-05-14 2021-05-25 Millennium Pharm Inc compostos que inibem quinase aurora e composição farmacêutica contendo os mesmos
TW200602314A (en) 2004-05-28 2006-01-16 Tanabe Seiyaku Co A novel pyrrolidine compound and a process for preparing the same
US20060014733A1 (en) * 2004-07-19 2006-01-19 Pfizer Inc Histamine-3 agonists and antagonists
SI1786790T1 (sl) 2004-07-26 2009-10-31 Lilly Co Eli Derivati oksazola kot agenti histamin h3 receptorja, priprava in terapevtska uporaba
AU2005277518B2 (en) 2004-08-23 2011-08-04 Eli Lilly And Company Histamine H3 receptor agents, preparation and therapeutic uses
UY29149A1 (es) 2004-10-07 2006-05-31 Boehringer Ingelheim Int Tiazolil-dihidro-indazoles
US7381732B2 (en) * 2004-10-26 2008-06-03 Bristol-Myers Squibb Company Pyrazolobenzamides and derivatives as factor Xa inhibitors
MX2007008843A (es) * 2005-01-21 2007-08-22 Schering Corp Derivados de imidazol y bencimidazol utiles como antagonistas de histamina h3.
KR20070108881A (ko) * 2005-01-27 2007-11-13 교와 핫꼬 고교 가부시끼가이샤 Igf-1r 저해제
JP2008537953A (ja) * 2005-04-15 2008-10-02 エラン ファーマシューティカルズ,インコーポレイテッド ブラジキニンb1受容体拮抗作用に有用な新規化合物
MX2008011791A (es) 2006-03-15 2008-09-25 Wyeth Corp Azaciclilaminas-n-sustituidas como antagonistas de histamina-3.
MX2008012054A (es) 2006-03-20 2008-10-02 Glaxo Group Ltd Compuestos que potencian el receptor del acido alfa-amino-3-hidroxi-5-metilisoxasol-4-propionico y usos de los mismos en medicina.
US20070238718A1 (en) 2006-04-06 2007-10-11 Matthias Grauert Thiazolyl-dihydro-indazole
PE20081152A1 (es) 2006-10-06 2008-08-10 Wyeth Corp Azaciclilaminas n-sustituidas como antagonistas de histamina-3

Similar Documents

Publication Publication Date Title
JP2009537542A5 (cg-RX-API-DMAC7.html)
JP2005526723A5 (cg-RX-API-DMAC7.html)
CN105051005B (zh) 环丙胺化合物及其用途
NZ616828A (en) Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
RU2012129737A (ru) Замещенные бензамидные производные
JP2017522346A5 (cg-RX-API-DMAC7.html)
JP2013056930A5 (cg-RX-API-DMAC7.html)
JP2018511587A5 (cg-RX-API-DMAC7.html)
JP2010506918A5 (cg-RX-API-DMAC7.html)
CA2529686C (en) 2-acylaminothiazole derivative or salt thereof
JP2014521653A5 (cg-RX-API-DMAC7.html)
JP2019505595A5 (cg-RX-API-DMAC7.html)
EP2009005A1 (en) Azolecarboxamide derivative
NZ593594A (en) Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
JP2017530185A5 (cg-RX-API-DMAC7.html)
JP2019504830A5 (cg-RX-API-DMAC7.html)
JP2018529770A5 (cg-RX-API-DMAC7.html)
JP2009513703A5 (cg-RX-API-DMAC7.html)
JP2011500697A5 (cg-RX-API-DMAC7.html)
JP2020502092A5 (cg-RX-API-DMAC7.html)
RU2019136279A (ru) C5 -Анилинохиназолиновые соединения и их использование в лечении рака
JP2009513575A5 (cg-RX-API-DMAC7.html)
HRP20201430T1 (hr) Spojevi 6-heterociklil-4-morfolin-4-ilpiridin-2-ona korisni za liječenje karcinoma i dijabetesa
JP2013530957A5 (cg-RX-API-DMAC7.html)
CA2702933A1 (en) Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof